European Companies Search Engine

EU funding (€4,613,500): Ultrafast Chirality for Life and Technology Hor 14 Jul 2025 EU Research and Innovation programme "Horizon"

Overview

Text

Ultrafast Chirality for Life and Technology

TRILOGY establishes the interface between the emerging field of Ultrafast Chirality and its Life and Technology applications by using attosecond electronic response to light, the fastest agent in mediating electric signals, highlighted by the 2023 Physics Nobel Prize. Chirality, a dissymmetry between a molecule and its mirror image, is a synonym of life: it enables metabolic reactions and stability of proteins. Abnormal chirality is an indicator for cancer cells, brain or kidney diseases, but its accurate detection requires a combination of high precision and speed, where attosecond response to light gives clear advantage to optical methods. Standard chiro-optical methods are fundamentally limited in accuracy by a ratio of molecular size to the light wavelength. Resolving ultrafast electron dynamics we remove this limitation and break into a new regime with chiral signals outperforming standard methods by several orders of magnitude. We will take advantage of this paradigm shift in chiral measurements and develop new efficient ultrafast spectroscopies for discriminating medium sized chiral biomolecules and elucidating charge and spin transport in chiral media at the most fundamental level: the level of electrons. We overlap the training and innovation landscapes in a unique way inspired by a common drive to bring cutting-edge scientific developments to applications, enabled by strong involvement of industry. We will (i) integrate our methods with existing analytics for quick market adaptation, working with the market leader for mass spectrometry (ThermoFisher), (ii) further them to unprecedentedly high throughput enabled by laser technology (Amplitude) and state-of-the-art imaging (PIimaging). We will make a difference, motivate and inspire young minds, training a new generation of researchers at the interface of fundamental science, technology and high-tech industry to bring cutting edge research through industrial applications to the benefit of the society.


Funded Companies:

Company name Funding amount
Amplitude ?
Centre National de la Recherche Scientifique CNRS €944,007
Consiglio Nazionale Delle Ricerche €563,510
Forschungsverbund Berlin e. V. €290,272
Heriot-Watt University €348,738
Imperial College of Science Technology and Medicine €348,738
Institut d'Optique Theorique et Appliquee Iota - Supoptique €314,669
Lunds Universitet €324,630
Thermo Fisher Scientific (Bremen) GmbH €290,272
Universite de Liege €288,540
University OF Hamburg €580,545
Weizmann Institute OF Science €319,577

Source: https://cordis.europa.eu/project/id/101226887

The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Amplitude SAS, Pessac, France.